ARTICLE | Company News
Ferrer, Vivia Biotech deal
December 17, 2012 8:00 AM UTC
The companies partnered to co-develop Vivia009 to treat blood cancers, including non-Hodgkin's lymphoma (NHL) and chronic lymphocytic leukemia (CLL). Vivia used its drug repositioning platform to dev...